Patent · US Expired

Dicyclanil polymorphs and hydrates and their preparation

US6255316A · kind A · utility

0Cited by

1References

19Claims

0Family size

Assignee

Novartis Animal Health U.S., Inc. · US

Inventors

Erwin Marti · Basel, CH
Walter Oechslein · Blaxland, AU
Andre Geoffroy · Habsheim, FR

Key dates

Filing date	Feb 22, 2000
Grant date	Jul 3, 2001
Priority date	—
Expiry date	Feb 22, 2020

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D239/50
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to several new, polymorphous crystal forms of Dicyclanil, and hydrates and solvates thereof, as well as the preparation thereof. In particular, the invention relates to substantially pure crystal forms of Dicyclanil, having characteristic lattice structures, which are effective for the control of insects and ectoparasites.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.